ribavirin has been researched along with Aging in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (50.00) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bose, ME; Chiu, MC; Chu, H; He, J; Henrickson, KJ; Ho-Yin Wong, B; Hu, M; Huang, JD; Li, C; Luo, YS; Shuai, H; Sun, Z; Wang, D; Wang, Y; Wen, L; Yang, D; Ye, ZW; Yuan, S; Zhang, K; Zhang, X; Zhao, H; Zhao, X; Zheng, B; Zhou, J | 1 |
Angeli, E; Caputo, A; Carosi, G; Cattelan, AM; Giralda, M; Iannacone, C; Maida, I; Nasta, P; Pontali, E; Puoti, M; Verucchi, G | 1 |
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Miyakawa, Y; Saitoh, S; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H | 1 |
Dai, Y; Ishii, K; Mohri, K; Motegi, E; Uesawa, Y | 1 |
Glória, H; Marinho, R; Nunes, J; Serejo, F; Velosa, J | 1 |
Aguilar-Reina, J; Barroso, N; González-Escribano, MF; Montes-Cano, MA; Núñez-Roldan, A; Romero-Gómez, M; Sánchez-Muñoz, D; Torres, B | 1 |
Fujiyama, S; Hamada, A; Saito, H; Sasaki, Y; Uchida, M; Yamasaki, M | 1 |
Alessandri, A; Franco, V; Giannitrapani, L; Montalto, G; Rappa, F; Soresi, M; Tripi, S; Vuturo, O | 1 |
Chen, EY; Gu, ZJ; Hwang, Y; Lin, E; Wang, SC | 1 |
Amagai, T; Cinader, B; Matsuzawa, T | 1 |
Allsop, J; Watts, RW | 1 |
Borghi, C; Cogo, R; Fraschini, F; Furcolo, F; Gattei, R; Maierna, G; Palazzini, E; Scaglione, F | 1 |
1 trial(s) available for ribavirin and Aging
Article | Year |
---|---|
Assessment of adverse reactions and pharmacokinetics of ribavirin in combination with interferon alpha-2b in patients with chronic hepatitis C.
Topics: Adult; Aged; Aging; Antiviral Agents; Drug Therapy, Combination; Female; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Platelet Count; Recombinant Proteins; Ribavirin | 2004 |
11 other study(ies) available for ribavirin and Aging
Article | Year |
---|---|
Establishment of a lethal aged mouse model of human respiratory syncytial virus infection.
Topics: Aging; Animals; Antiviral Agents; Cell Line; Cyclophosphamide; Disease Models, Animal; Genome, Viral; Humans; Lung; Mice; Mice, Inbred BALB C; Mutation; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Virus Replication | 2019 |
Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women.
Topics: Adult; Aging; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Glucose; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Italy; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load | 2015 |
Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads.
Topics: Adult; Aged; Aging; Antiviral Agents; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Sex Characteristics; Viral Load; Young Adult | 2009 |
[Relationship between patient profile and feverishness developed during interferon-ribavirin combination therapy of chronic hepatitis C patients].
Topics: Adult; Aged; Aging; Antiviral Agents; Drug Therapy, Combination; Female; Fever; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Severity of Illness Index; Sex Characteristics | 2008 |
Eradication of hepatitis C virus reduces the risk of hepatocellular carcinoma in patients with compensated cirrhosis.
Topics: Adult; Aging; Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Ribavirin | 2011 |
HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C.
Topics: Adult; Aging; Alleles; Antiviral Agents; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Histocompatibility Antigens Class II; HLA-B Antigens; HLA-B44 Antigen; Humans; Interferons; Middle Aged; Multivariate Analysis; Ribavirin; Treatment Outcome; Tumor Necrosis Factor-alpha | 2003 |
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.
Topics: Adult; Aging; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Body Mass Index; Drug Therapy, Combination; Fatty Liver; Female; gamma-Glutamyltransferase; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index; Treatment Outcome | 2006 |
An artificial neural network approach to the drug efficacy of interferon treatments.
Topics: Aging; Algorithms; Antiviral Agents; Drug Therapy, Combination; Forecasting; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Immunologic Factors; Interferons; Neural Networks, Computer; Polymorphism, Single Nucleotide; Reproducibility of Results; Ribavirin; Sex Characteristics; Signal Transduction; Viral Load | 2006 |
The effect of ribavirin and rifamycin SV on age-dependent changes of the immune system during the adult life of SJL mice.
Topics: Aging; Animals; Female; Immune Tolerance; Immunity; Male; Mice; Mice, Inbred Strains; Ribavirin; Ribonucleosides; Rifamycins; T-Lymphocytes; T-Lymphocytes, Regulatory | 1982 |
Purine de novo synthesis in liver and developing rat brain, and the effect of some inhibitors of purine nucleotide interconversion.
Topics: Aging; Alanine; Allopurinol; Animals; Animals, Newborn; Anti-Bacterial Agents; Azaserine; Brain; Female; Fetus; Liver; Male; Pregnancy; Purine Nucleotides; Purines; Rats; Rats, Inbred Strains; Ribavirin; Ribonucleosides | 1983 |
Ribavirin influence on theophylline plasma levels in adult and children.
Topics: Aged; Aging; Child; Delayed-Action Preparations; Drug Interactions; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Ribavirin; Ribonucleosides; Theophylline | 1988 |